REGIMEN FOR SKIN INFECTIONS

Article

New data suggest InterMune Inc.'s intravenous oritavancin is as effective as a regimen of vancomycin plus cephalexin in treating patients with complicated skin and skin-structure infections (CSSSI).

Related Videos
Related Content

Research Finds Dermatology Visits for Acne Higher in Adult Female Patients

September 21st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Patients With Acne Vulgaris Did Not Display Significant Resistance Differences Versus 7 Antibiotics

September 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

Hyaluronic Acid-Based Fillers Effective in Treating Signs of Aging

September 20th 2023

Research Finds Dermatology Visits for Acne Higher in Adult Female Patients

September 21st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Patients With Acne Vulgaris Did Not Display Significant Resistance Differences Versus 7 Antibiotics

September 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

Hyaluronic Acid-Based Fillers Effective in Treating Signs of Aging

September 20th 2023

Research Finds Dermatology Visits for Acne Higher in Adult Female Patients

September 21st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Patients With Acne Vulgaris Did Not Display Significant Resistance Differences Versus 7 Antibiotics

September 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

Hyaluronic Acid-Based Fillers Effective in Treating Signs of Aging

September 20th 2023
© 2023 MJH Life Sciences

All rights reserved.